← Leaderboards
Elizabeth Devon Smith
Pennsylvania State Univ Hershey Med Ctr
$2,327,927
Attributed
$6,768,691
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2023–25$5M$3.8M$2.5M$1.3M$0
'23
'24
'25
Funding mix
By agency
NIH$6,768,691 · 4
By mechanism
UH3$3,477,195 · 1
UG3$1,851,722 · 1
R01$1,439,774 · 2
Top collaborators
- Daniel J Buysse4 shared
- Julio Fernandez-Mendoza4 shared
- Charles M. Morin4 shared
- Jennifer L Taylor-Cousar4 shared
- Alexandros N Vgontzas4 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Alexandros N Vgontzas$3,874,274
- Julio Fernandez-Mendoza$6,504,747
- Patricia Sue Grigson$14,004,500
- Scott C Bunce$5,738,704
Others in their field
Other Rising Stars on “Symptoms”
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- John Alam · Eip Pharma, Inc.$10,411,018
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Michael E. Roth · Public Health Institute$8,201,777
Research focus
SymptomsDisease RemissionSleeplessnessSeveritiesSleepSecondary OutcomeSamplingPharmaceutical PreparationsDiariesActigraphyResponseClinical PracticePatient Self-ReportParticipantPrimary OutcomeAdultRandomizedBlindGuidelinesIndexingClinical PhenotypeCharacteristicsDouble-Blind MethodCardiovascular System
Grant awards (7)
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$1,467,809
UH3 · FY2025 · HL
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$262,705
UH3 · FY2025 · HL
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$1,746,681
UH3 · FY2024 · HL
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy$538,289
R01 · FY2024 · DA · contact PI
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$1,851,722
UG3 · FY2023 · HL
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy$535,473
R01 · FY2023 · DA · contact PI
Use of blinded tapering for hypnotic discontinuation$366,012
R01 · FY2023 · DA · contact PI